Furthermore, although overexpression or dysregulated function of cdk6 has been implicated in several types of cancer, including lymphoid malignancies [13], squamous cell carcinomas [14], and neuroblastomas [15], levels of cdk6 are decreased in many breast tumors and most breast tumor-derived cell lines [12], [16]. This evidence concerns the gene CDK6 and neuroblastoma.